A detailed history of Knollwood Investment Advisory, LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Knollwood Investment Advisory, LLC holds 1,628,510 shares of ABOS stock, worth $2.88 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
1,628,510
Previous 1,628,510 -0.0%
Holding current value
$2.88 Million
Previous $3.94 Billion 2.48%
% of portfolio
0.43%
Previous 0.44%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$4.15 - $9.72 $207,500 - $486,000
-50,000 Reduced 2.98%
1,628,510 $6.76 Billion
Q4 2022

Nov 14, 2023

BUY
$4.81 - $10.17 $8.07 Million - $17.1 Million
1,678,510 New
1,678,510 $9.06 Billion

Others Institutions Holding ABOS

About Acumen Pharmaceuticals, Inc.


  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $71.7M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Knollwood Investment Advisory, LLC Portfolio

Follow Knollwood Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knollwood Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knollwood Investment Advisory, LLC with notifications on news.